Researchers Identify a Possible Circadian Subtype of Depression
Clinical and genetic data suggest that some people with depression may have symptoms strongly linked to the body's internal clock.
Medical Xpress reported on 21 October that University of Sydney researchers identified a possible subtype called “circadian depression” in data from more than 10,000 Australians with severe, recurrent or persistent depression. About one-quarter of participants in the study were classified in this group.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Depression can affect mood, motivation, concentration, sleep and daily functioning. However, the condition does not present identically in every person. Some people experience major disruptions to their sleep-wake cycle, including sleeping longer than usual, waking unrefreshed or having a strong tendency to stay awake late at night.
Researchers from the University of Sydney examined clinical and genetic data from the Australian Genetics of Depression Study. They identified a group whose symptoms appeared more closely linked to circadian rhythms—the internal biological processes that regulate sleep and wakefulness over roughly 24 hours.
The researchers suggested that recognising such patterns could help clinicians study whether treatments targeting sleep timing and circadian regulation may be useful for some patients. Approaches under investigation include structured behavioural interventions, light therapy and treatments affecting melatonin pathways.
The findings do not mean that circadian depression is already a universally accepted diagnostic category, or that the same treatment will work for everyone in the group. Independent replication and clinical trials are needed to establish how best to use this information.
People experiencing persistent depression should seek professional assessment. They should not start light therapy or change antidepressant medication without appropriate clinical advice.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
